Skip to main navigation Skip to search Skip to main content

Stereotactic body radiotherapy with functional treatment planning in hepatocellular carcinoma

Alexander Kirichenko, Eugene J. Koay, Shaakir Hasan, Christopher Crane

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Hepatocellular carcinoma (HCC) is the fastest growing cause of cancer-related death in the United States, and considered an aggressive tumor with mean survival estimated between 6 and 20 months (El-Serag, NEJM 365:1118–1127, 2011). The choice of curative liver resection is limited by the presence of hepatic cirrhosis in 90% of patients, and the most appropriate therapy for HCC has historically been hepatic transplantation with 5-year survival rate of up to 85%. However, only 10% of patients are eligible for surgery (Fortune et al., J Clin Gastroenterol 47:S37–S42, 2013). We discuss functional treatment planning for patients with hepatic cirrhosis and HCC and present an argument in favor of liver SBRT as a viable option.

Original languageEnglish (US)
Title of host publicationMedical Radiology
PublisherSpringer-Verlag
Pages203-210
Number of pages8
DOIs
StatePublished - Jan 1 2018

Publication series

NameMedical Radiology
ISSN (Print)0942-5373
ISSN (Electronic)2197-4187

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'Stereotactic body radiotherapy with functional treatment planning in hepatocellular carcinoma'. Together they form a unique fingerprint.

Cite this